Growth inhibition in clonal subpopulations of a human epithelioid sarcoma cell line by retinoic acid and tumour necrosis factor alpha

British Journal of Cancer

Volumn 73, Issue 4, 1996, Pages 491-498

  Engers, R ^a   Van Roy, F ^b   Heymer, T ^a   Ramp, U ^a   Moll, R ^c   Dienst, M ^a   Friebe, U ^a   Pohl, A ^a   Gabbert, H E ^a   Gerharz, C D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b GHENT UNIVERSITY   (Belgium)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Epithelioid sarcoma; Growth inhibition; Retinoic acid; Tumour necrosis factor

Indexed keywords

RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EPITHELIOID SARCOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; SOFT TISSUE SARCOMA;

EID: 9044227262     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.86     Document Type: Article

References (41)

1. ALLEY MC, SCUDIERO DA, MONKS A, CZERWINSKI MJ, FINE DL, ABBOTT BJ, MAYO JG, SHOEMAKER RH AND BOYD MR. (1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res., 48, 589-601.
2. BEYAERT R AND FIERS W. (1994). Molecular mechanisms of tumor necrosis factor-induced cytotoxicity - what we do understand and what we do not. FEBS Lett., 340, 9-16.
3. CHAMBON P. (1993). The molecular and genetic dissection of the retinoid signalling pathway. Gene, 135, 223-228.
4. CHASE DR AND ENZINGER FM. (1985). Epithelioid sarcoma; diagnosis, prognostic indicators, and treatment. Am. J. Surg. Pathol., 9, 241-263.
5. CHROMCZYNSKI P AND SACCHI N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
6. DEBUS E, WEBER K AND OSBORN M. (1983). Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides. Differentiation, 25, 193-203.
7. ENGERS R, GERHARZ CD, MOLL R, POHL A, SARBIA M AND GABBERT HE. (1994). Interclonal heterogeneity in a human epithelioid sarcoma cell line (GRU-1). Int. J. Cancer. 59, 548-553.
8. ENZINGER FM. (1970). Epithelioid sarcoma. A sarcoma simulating a granuloma or a carcinoma. Cancer, 26, 1029-1041.
9. FERRARI N, PFEFFER U, TOSETTI F, BRIGATI C AND VIDALI G. (1994). An improved RT-PCR protocol for the quantification of human retinoic acid receptor RNA. Exp. Cell. Res., 211, 121-126.
10. GABBERT HE, GERHARZ CD, BIESALSKI HK, ENGERS R AND LULEY C. (1988). Terminal differentiation and growth inhibition of a rat rhabdomyosarcoma cell line (BA-HAN-1C) in vitro after exposure to retinoic acid. Cancer Res., 48, 5264-5269.
11. GERHARZ CD, MOLL R, RAMP U, MELLIN W AND GABBERT HE. (1990). Multidirectional differentiation in a newly established human epithelioid sarcoma cell line (GRU-1) with co-expression of vimentin, cytokeratins and neurofilament proteins. Int. J. Cancer, 45, 143-152.
12. GERHARZ CD, BRACKE ME, MAREEL MM AND GABBERT HE. (1993). Modulation of invasive potential in different clonal subpopulations of a rat rhabdomyosarcoma cell line (BA-HAN-1) by differentiation induction. Clin. Exp. Metastasis, 11, 55-67.
13. GRELL M, SCHEURICH P, MEAGER A AND PFIZENMAIER K. (1993). TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymph. Cytok. Res., 12, 143-148.
14. HALEVY O AND LERMAN O. (1993). Retinoic acid induces adult muscle cell differentiation mediated by retinoic acid receptor-α. J. Cell Physiol., 154, 566-572.
15. HELLER RA, SONG K, FAN N AND CHANG DJ. (1992). The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell, 70, 47-56.
16. HIGUCHI M AND AGGARWAL BB. (1994). Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation, and differentiation. J. Immunol., 152, 4017-4025.
17. JOYCE DA AND STEER JH. (1992). Differentiation of the U-937 promonocytic cell line induced by phorbol myristate acetate or retinoic acid: effect of aurothiomolate. Agents Actions, 37, 305-310.
18. LEJEUNE F, LIENARD D, EGGERMONT A, SCHRAFFORDT-KOOPS H, KROON B, GERAIN J, ROSENKAIMER F AND SCHMITZ P. (1994a). Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma. Circ. Shock, 43, 191-197.
19. LEJEUNE F, LIENARD D, EGGERMONT A, SCHRAFFORDT-KOOPS H, ROSENKAIMER F, GERAIN J, KLAASE J, KROON B, VANDERVEKEN J AND SCHMITZ P. (1994b). Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma. J. Cell. Biochem., 56, 52-61.
20. MCGARVEY TW, SILBERMAN S AND PERSKY B. (1990). The effect of butyric acid and retinoic acid on invasion and experimental metastasis of murine melanoma cells. Clin. Exp. Metastasis, 8, 433-448.
21. MANGELSDORF DJ. (1994). Vitamin A receptors. Nutr. Rev., 52, 32-44.
22. MARKS SM, HALLENBECK PL, NAGATA T, SEGARS JH, APPELLA E, NIKODEM VM AND OZATO K. (1992). H-2RIIBP (RXRβ) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J., 11, 1419-1435.
23. MOLL R, ACHTSTÄTTER T, BECHT E, BALCAROVA-STÄNDER J, ITTENSOHN M AND FRANKE WW. (1988). Cytokeratins in normal and malignant transitional epithelium: maintenance of expression of urothelial differentiation features in transitional-cell carcinomas and bladder carcinoma cell lines. Am. J. Pathol., 132, 123-144.
24. MUMMERY CL, VAN DEN BRINK CE, VAN DER SAAG PT AND DE LAAT SW. (1984). The cell cycle, cell death, and cell morphology during retinoic-acid induced differentiation of embryonal carnicoma cells. Dev. Biol., 104, 297-307.
25. NAGPAL S, FRIANT S, NAKSHATRI H AND CHAMBON P. (1993). RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO J., 12, 2349-2360.
26. PITZ S, MOLL R, STÖRKEL S AND THOENES W. (1987). Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Lab. Invest., 6, 642-653.
27. PRAT J, WOODRUFF JM AND MARCOVE RC. (1978). Epithelioid sarcoma: an analysis of 22 cases indicating the prognostic significance of vascular invasion and regional lymph-node metastasis. Cancer, 41, 1472-1487.
28. PUSZTAI L, LEWIS CE AND MCGEE JO. (1993). Growth arrest of the breast cancer cell line, T47D, by TNFalpha - cell cycle specificity and signal transduction. Br. J. Cancer, 67, 290-296.
29. REEVES BR, FISHER C, SMITH S, COURTENAY VD AND ROBERTSON D. (1987). Ultrastructural, immunocytochemical, and cytogenetic characterization of a human epithelioid sarcoma cell line (RM-HS1). J. Natl Cancer Inst., 78, 7-18.
30. RUTKA JT, GIBLIN JR, BERENS ME, BAR-SHIVA E, TOKUDA K, MCCULLOCH JR, ROSENBLUM ML, EESSALU TE, AGGARWAL BB AND BODELL WJ. (1988). The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies. Int. J. Cancer, 41, 573-582.
31. SCHEURICH P, THOMA B, ÜCER U AND PFIZENMAIER K. (1987). Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-α: induction of the TNF receptors on human T cells and TNF-α-mediated enhancement of T cell response. J. Immunol., 138, 1786-1790.
32. SCUDIERO DA, SHOEMAKER RH, PAULL KD, MONKS A, TIERNEY S, NOFZINGER TH, CURRENS MJ, SENIFF D AND BOYD MR. (1988). Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res., 48, 4827-4833.
33. SIDHU RS AND BOLLON AP. (1993). Tumor necrosis factor activities and cancer therapy - a perspective. Pharmacol. Ther., 57, 79-128.
34. SONOBE H, FURIHATA M, IWATA J, OKA T, OHTSUKI Y, HAMASATO S AND FUJIMOTO S. (1993). Morphological characterization of a new human epithelioid sarcoma cell line, ES020488, in vitro and in vivo. Virchows Arch. B., 63, 219-225.
35. STALLCUP MR AND WASHINGTON LD. (1983). Region-specific initiation of mouse mammary tumor virus RNA synthesis by endogenous RNA polymerase II in preparations of cell nuclei. J. Biol. Chem., 258, 2802-2807.
36. SUGARMAN BJ, AGGARWAL BB, HASS PE, FIGARI IS, PALLADINO JR MA AND SHEPARD HM. (1985). Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science, 230, 943-945.
37. TARTAGLIA LA AND GOEDDEL DV. (1992). Two TNF receptors. Immunol. Today, 13, 151-153.
38. TARTAGLIA LA, ROTHE M, HU Y-F AND GOEDDEL DV. (1993). Tumor necrosis factor's cytotoxic activity is signaled by p55 TNF receptor. Cell. 73, 213-216.
39. VAN DER LEEDE BM, VAN DEN BRINK CE AND VAN DER SAAG PT. (1993). Retinoic acid and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines. Mol. Carcinogen., 8, 112-122.
40. VANHAESEBROECK B, VAN BLADEL S, LENAERTS A, SUFFYS P, BEYAERT R, LUCAS R, VAN ROY F AND FIERS W. (1991). Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line. Cancer Res., 51, 2469-2477.
41. VANHAESEBROECK B, DECOSTER E, VAN OSTADE X, VAN BLADEL S, LENAERTS A, VAN ROY F AND FIERS W. (1992). Expression of an exogenous tumor necrosis factor (TNF) gene in TNF-sensitive cell lines confers resistance to TNF-mediated cell lysis. J. Immunol. 148, 2785-2794.